CBS 2019
CBSMD教育中心
中 文

Other Relevant Articles

Abstract

Recommended Article

Utilization and programming of an automatic MRI recognition feature for cardiac rhythm management devices The HACD4 haplotype as a risk factor for atherosclerosis in males Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion: The DECISION-CTO Trial Development and validation of a simple risk score to predict 30-day readmission after percutaneous coronary intervention in a cohort of medicare patients From Nonclinical Research to Clinical Trials and Patient-registries: Challenges and Opportunities in Biomedical Research Outcomes in Women and Minorities Compared With White Men 1 Year After Everolimus-Eluting Stent Implantation: Insights and Results From the PLATINUM Diversity and PROMUS Element Plus Post-Approval Study Pooled Analysis Cholesterol-Lowering Agents LOX-1 in Atherosclerosis and Myocardial Ischemia: Biology, Genetics, and Modulation

Review Article2019 Feb;124(3):364-385.

JOURNAL:Circ Res. Article Link

Cholesterol-Lowering Agents

Rosenson RS, Hegele RA, Koenig W. Keywords: cardiovascular disease; cholesterol; myocardial infarction; patients; subtilisin

FULL TEXT PDF